Aimovig 70 mg erenumab pre‑filled pen (refrigerated)

• • Aimovig is a prescription medicine used to help prevent migraine in adults.

• Aimovig is the first FDA-approved treatment that blocks the CGRP receptor to help prevent migraine.

How To Use:

For subcutaneous use only

• • Recommended dosage is 70 mg once monthly; some patients may benefit from a dosage of 140 mg once monthly.

• • Administer in the abdomen, thigh, or upper arm subcutaneously.

• • Recommended dosage is 70 mg once monthly; some patients may benefit from a dosage of 140 mg once monthly.

• • Administer in the abdomen, thigh, or upper arm subcutaneously.

Warnings And Precautions:

• • Do not use Aimovig® if you are allergic to erenumab-aooe or any ingredients in Aimovig.

Before starting Aimovig, tell your healthcare provider (HCP) about all your medical conditions, including:

• • If you are allergic to rubber or latex.

• • Pregnant or plan to become pregnant, breastfeeding or plan to breastfeed.

• • Tell your hcp about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements.

Ingredients:

• 70 mg/mL solution in a single-dose prefilled SureClick® autoinjector